PlumX Metrics
Embed PlumX Metrics

Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera

Haematologica, ISSN: 0390-6078, Vol: 94, Issue: 3, Page: 414-418
2009
  • 66
    Citations
  • 0
    Usage
  • 65
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Article Description

To further characterize JAK2 exon 12 mutations, we performed molecular screening in 409 patients with polycythemia vera or unclear erythrocytosis with unmutated JAK2V617. The frequency of JAK2exon12 mutations was 10/63 (15.9%) in PV but only 5/346 (1.4%) in the erythrocytosis cases. Nine different mutations including four new types (D544-L545del, H538DK539LI540S, H538-K539del, V536-F547dup) were detected. In 2 cases we found evidence for the presence of cells homozygous for mutated JAK2exonl2. As this as the case in only 2/15 cases with JAK2exonl2 mutations (13%) homozygosity seemed to be less frequent than in V617F-mutated polycythemia vera (69%) (p<0.001). There were more females than males in the group of patients with a JAK2exonl2 mutation (10 vs. 5) compared to the group with wildtype JAK2 (132 vs. 262; p=0.012). Median age of onset was lower than in the V617Fmut controls (58.5 vs. 67.8 years, p<0.001). In conclusion, JAK2 exon 12 mutation analysis contributes to diagnostics in polycythemia vera or erythrocytosis. © 2009 Ferrata Storti Foundation.

Bibliographic Details

Schnittger, Susanne; Bacher, Ulrike; Haferlach, Claudia; Geer, Thomas; Müller, Peter; Mittermüller, Johann; Petrides, Petro; Schlag, Rudolf; Sandner, Reiner; Selbach, Johannes; Slawik, Hans Rainer; Tessen, Hans Werner; Wehmeyer, Jürgen; Kern, Wolfgang; Haferlach, Torsten

Ferrata Storti Foundation (Haematologica)

Medicine

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know